ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

GMAB Genmab AS

29.73
2.01 (7.25%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Genmab AS GMAB 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
2.01 7.25% 29.73 08:05:20
개장가 저가 고가 종가 전일 종가
29.73 29.46 29.92 29.72 27.72
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202407:40BWFDA Grants Full Approval for TIVDAK® to Treat Recurrent or..
03/04/202414:35BWGenmab to Broaden and Strengthen Oncology Portfolio with..
12/03/202402:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/03/202403:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/03/202403:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/03/202407:04EDGAR2Form 144 - Report of proposed sale of securities
01/03/202401:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/02/202401:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/02/202406:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/02/202421:45BWU.S. FDA Accepts for Priority Review the Supplemental..
27/02/202402:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/02/202400:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/02/202406:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/02/202401:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202405:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202403:49EDGAR2Form 20-F - Annual and transition report of foreign private..
15/02/202402:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/02/202420:45BWTisotumab Vedotin Marketing Authorization Application..
01/02/202401:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/01/202423:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/01/202421:45DJNPfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval
09/01/202420:45BWTIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
03/01/202422:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/12/202301:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202302:00BWNew Pivotal Data for Bispecific Antibody Epcoritamab..
02/12/202303:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/11/202321:00BWGenmab Announces Positive Regulatory Updates for Epcoritamab..
22/11/202306:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/11/202300:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202302:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202301:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/11/202322:05BWGenmab Announces Multiple Abstracts to be Presented at the..
22/10/202323:30BWTIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged..
17/10/202321:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202323:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/09/202305:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/09/202321:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/09/202321:50DJNAbbVie, Genmab Get Conditional Europe OK of Tepkinly..
25/09/202320:45BWGenmab Announces European Commission Approval of TEPKINLY®..
25/09/202318:55BWEPKINLY™ (epcoritamab) Approved by Japan Ministry of Health,..
13/09/202322:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/09/202304:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/202322:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/09/202304:00BWSeagen and Genmab Announce TIVDAK® (tisotumab vedotin-tftv)..
17/08/202302:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/08/202304:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/08/202300:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/07/202322:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/07/202317:30BWGenmab Announces AbbVie Receives Positive CHMP Opinion for..
20/07/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

Delayed Upgrade Clock